Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock
Recruiting · NCT05969275 · Registry updated 2024-12-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock | Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, toxic shock syndrome | Recruiting | Phase 2 | 2024-12-05 | NCT05969275 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Ottawa Hospital (Civic Campus) | Ottawa | Canada | 1 |
| The Ottawa Hospital (General Campus) | Ottawa | Canada | 1 |